title: CYLD regulates keratinocyte differentiation and skin cancer progression in humans.
abstract: CYLD is a gene mutated in familial cylindromatosis and related diseases, leading to the development of skin appendages tumors. Although the deubiquitinase CYLD is a skin tumor suppressor, its role in skin physiology is unknown. Using skin organotypic cultures as experimental model to mimic human skin, we have found that CYLD acts as a regulator of epidermal differentiation in humans through the JNK signaling pathway. We have determined the requirement of CYLD for the maintenance of epidermal polarity, keratinocyte differentiation and apoptosis. We show that CYLD overexpression increases keratinocyte differentiation while CYLD loss of function impairs epidermal differentiation. In addition, we describe the important role of CYLD in the control of human non-melanoma skin cancer progression. Our results show the reversion of the malignancy of human squamous cell carcinomas that express increased levels of CYLD, while its functional inhibition enhances the aggressiveness of these tumors which progress toward spindle cell carcinomas. We have found that the mechanisms through which CYLD regulates skin cancer progression include the control of tumor differentiation, angiogenesis and cell survival. These findings of the role of CYLD in human skin cancer prognosis make our results relevant from a therapeutic point of view, and open new avenues for exploring novel cancer therapies.
authors: Division of Epithelial Biomedicine, CIEMAT, Madrid, Spain.
authors: J P
authors: JP
authors: Alameda
authors: M J
authors: MJ
authors: Fernández-Aceñero
authors: R
authors: R
authors: Moreno-Maldonado
authors: M
authors: M
authors: Navarro
authors: R
authors: R
authors: Quintana
authors: A
authors: A
authors: Page
authors: A
authors: A
authors: Ramírez
authors: A
authors: A
authors: Bravo
authors: M L
authors: ML
authors: Casanova
mesh_terms: D000818:Animals; D017209:Apoptosis; D002277:Carcinoma / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation; D002460:Cell Line; D000074749:Deubiquitinating Enzyme CYLD; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D015603:Keratinocytes / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D009389:Neovascularization, Pathologic; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology*; D014183:Transplantation, Heterologous; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D025521:Tumor Suppressor Proteins; D048031:JNK Mitogen-Activated Protein Kinases; C409984:CYLD protein, human; D000074749:Deubiquitinating Enzyme CYLD